A new study explains how pancreatic tumors use a sugar coating to hide from the immune system and shows that a newly ...

Lung cancer patients receiving immunochemotherapy earlier in the day had a 52% lower risk of progression in a new medical ...

Researchers demonstrated that newly developed molecules designed to block an immune checkpoint can trigger a powerful immune response against tumors. Scientists at MIT and Stanford University have ...

Gold nanoparticles that cluster in response to T cell enzymes can predict cancer immunotherapy success days before tumors ...

Former Senator Ben Sasse announced his stage 4 pancreatic cancer diagnosis in 2025, calling it "a death sentence" while ...

Datopotamab deruxtecan received FDA approval for HR+/HER2– breast cancer, improving progression-free survival and overall ...

Scientists have identified a promising strategy to improve liver cancer immunotherapy: targeting B-cells. While immunotherapy has transformed cancer treatment by activating T-cells—a type of immune ...

Researchers at the Johns Hopkins Kimmel Cancer Center's Ludwig Center developed a new treatment that selectively targets ...

Gastrointestinal cancers that once resisted checkpoint inhibitors are finally responding to novel combination strategies([1]) , with the FDA fast-tracking multiple targeted therapies designed to ...

Children with peanut allergies may not need large doses of peanut oral immunotherapy (OIT) to build protection against ...

Libtayo's approval for high-risk cutaneous squamous cell carcinoma offers a new immunotherapy option, targeting PD-1 ...

Could immunotherapy, a type of cancer treatment that uses your body’s own immune system to fight tumors, help people with mesothelioma? Early research shows benefits for this hard-to-treat form of ...